Loss of Certain Protein Identified in Ovarian Cancer Resistance to PARP Inhibitors
News
Researchers have identified a mechanism of resistance to PARP inhibitors — such as Lynparza (olaparib) and — in ovarian cancer, that involves the loss of a specific protein called 53BP1, according to ... Read more